Tietueen sitaatit

APA-viite (7. p.)
Kleytman, N., Ruan, J., Ruan, A., Zhang, B., Murugesan, V., Lin, H., . . . Mistry, P. K. (2021). Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease. Elsevier.
Chicago-viite (17. p.)
Kleytman, Nathaniel, Jiapeng Ruan, Audrey Ruan, Bailin Zhang, Vagishwari Murugesan, Haiqun Lin, Lilu Guo, Katherine Klinger, ja Pramod K. Mistry. Incremental Biomarker and Clinical Outcomes After Switch from Enzyme Therapy to Eliglustat Substrate Reduction Therapy in Gaucher Disease. Elsevier, 2021.
MLA-viite (9. p.)
Kleytman, Nathaniel, et al. Incremental Biomarker and Clinical Outcomes After Switch from Enzyme Therapy to Eliglustat Substrate Reduction Therapy in Gaucher Disease. Elsevier, 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.